SCHEMBL16257563

SCHEMBL16257563

Cc1c(Nc2cc3ccccc3c(C)n2)ncnc1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMO O15229 1/20 0.36
PDE10A Q9Y233 1/20 0.36
CSNK2A2 P19784 4/20 0.35
CSNK2B P67870 4/20 0.35
CSNK2A1 P68400 4/20 0.35
EGFR P00533 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
MAPK1 P28482 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257576 0.78 ANO1 (0.49) EGFRABCG2KDRAURKAAURKB
SCHEMBL16257589 0.76 CSNK2A2 (0.48) ALDH1A1KDM4EMEN1GLAHPGD
SCHEMBL12539809 0.68 ADORA3 (0.49) KDM4ELMNAAURKB
Isophthalic Acid SCHEMBL27798930 0.68 CDC25B (0.44) ALDH1A1KDM4EMEN1CYP1A2GLA
SCHEMBL18924951 0.67 KMO (0.43) ALDH1A1KDM4ECYP1A2HPGDCYP2C19
SCHEMBL15033668 0.67 KMO (0.58) MEN1KMT2AHSD17B10KMOEGFR
SCHEMBL16257514 0.67 KDM4E (0.46) KDM4EEGFRMAPK1ABCG2
SCHEMBL30420994 0.66 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1CYP1A2GLA
SCHEMBL1202533 0.66 ALDH1A1 (0.50) ALDH1A1KDM4EMEN1CYP1A2GLA
SCHEMBL16257609 0.66 CSF1R (0.47) ALDH1A1KDM4EMEN1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed